Prospective, randomized trial of rapamycin [sirolimus] plus estradiol-eluting stents versus rapamycin-eluting stents for the reduction of coronary restenosis (ISAR-PEACE)

Trial Profile

Prospective, randomized trial of rapamycin [sirolimus] plus estradiol-eluting stents versus rapamycin-eluting stents for the reduction of coronary restenosis (ISAR-PEACE)

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2007

At a glance

  • Drugs Estradiol; Sirolimus
  • Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms ISAR-PEACE
  • Most Recent Events

    • 27 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top